Viral respiratory tract infections diagnosis: a Spanish survey and consensus approach
- PMID: 40354688
- DOI: 10.1016/j.diagmicrobio.2025.116831
Viral respiratory tract infections diagnosis: a Spanish survey and consensus approach
Abstract
Background: Respiratory tract infections (RTI) rank second cause of adult and paediatric morbidity and mortality worldwide. Clinical symptoms of acute respiratory infections (ARIs) do not allow to differentiate one from another. The etiological diagnosis of viral respiratory infections has undergone changes throughout the 21st century pandemics. In Spain there is still no consensus on the use of molecular tools for the diagnosis of viral RTI.
Methods: A panel of specialists from various Spanish Scientific Societies was gathered to discuss about the application of diagnostic techniques for respiratory viruses. A Delphi panel was conducted throughout 3 rounds, respondents being asked to rate their agreement level to provide evidence-based consensus methods to enable rapid and accurate diagnosis of viral RTI.
Results: The Delphi panel of experts reached a strong consensus that viral infections are the main cause of ARI, with Influenza, RSV, and SARS-CoV-2 identified as the most significant pathogens. These viruses are also the leading cause of ARI-related complications in vulnerable patients with risk factors for severe disease. In hospital settings, all symptomatic ARI patients should undergo rapid PCR testing for these three viruses, a measure of critical importance for immunocompromised individuals, the very elderly, and those with comorbidities that may worsen clinical outcomes.
Conclusion: Experts main concern was directed towards the need to inform and familiarize non-specialists about the relevance of specific viral diagnosis result of this diagnostic approach would be the reduction of antibiotic use for hospital and primary health providers.
Keywords: Diagnostic; Respiratory tract infections; Virus.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Raul Ortiz de Lejarazu reports financial support was provided by Cepheid Ltd. Jose Maria Eiros reports financial support was provided by Cepheid Ltd. F-V-Á declares having attended or participated in activities organized or funded by the pharmaceutical companies Almiral, Bial, Boehringer Ingelhiem, Chiesi, GlaxoSmithKline, Esteve, Ferrer, Menarini, Novartis, Mundipharma, Orion, Oximesa, Pfizer, Teva and Zambon. A-B-J declares having attended, organized or participated in activities organized or funded by the pharmaceutical companies Biomerieux, Biomerieux Italfármaco, Ordesa, Johnson and Johnson, AstraZeneca y Enanta Pharmaceutical. OSM holds ownership of several start-up companies in the healthcare field and has had in the past stock ownership of ‘Top 10′ pharmaceutical companies. He has received consulting fees from these companies. All authors declare no conflict of interest. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Multiplex PCR Detection of Respiratory Tract Infections in SARS-CoV-2-Negative Patients Admitted to the Emergency Department: an International Multicenter Study during the COVID-19 Pandemic.Microbiol Spectr. 2022 Oct 26;10(5):e0236822. doi: 10.1128/spectrum.02368-22. Epub 2022 Sep 26. Microbiol Spectr. 2022. PMID: 36154273 Free PMC article.
-
Analytical and clinical validation of a novel, laboratory-developed, modular multiplex-PCR panel for fully automated high-throughput detection of 16 respiratory viruses.J Clin Virol. 2024 Aug;173:105693. doi: 10.1016/j.jcv.2024.105693. Epub 2024 May 16. J Clin Virol. 2024. PMID: 38820916
-
Epidemiology and Clinical impact of single and multi-viral respiratory infections in post-pandemic era.New Microbiol. 2024 May;47(1):28-32. New Microbiol. 2024. PMID: 38700880
-
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).Eur Respir J. 2020 Oct 1;56(4):2001727. doi: 10.1183/13993003.01727-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32586885 Free PMC article. Review.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2020 Nov 20;11(11):CD006207. doi: 10.1002/14651858.CD006207.pub5. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2023 Jan 30;1:CD006207. doi: 10.1002/14651858.CD006207.pub6. PMID: 33215698 Free PMC article. Updated.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous